Animal Health Pipelines
Animal Health Infectious Diseases Pipeline
DISEASE & PRODUCT
RESEARCH
OPTIMIZATION
PRE-CLINICAL
PHASE I
PHASE II
PHASE III
MARKET LAUNCH
Rabies Vaccine
Pre-Clinical
Pre-Clinical
Leishmania Vaccine
Optimization
Optimization
Porcine PCV2 Vaccine
Optimization
Optimization
Foot and Mouth Diseases Vax
Optimization
Optimization
Animal Health Chronic Non-Communicable Diseases Pipeline
DISEASE & PRODUCT
RESEARCH
OPTIMIZATION
PRE-CLINICAL
PHASE I
PHASE II
PHASE III
MARKET LAUNCH
Canine Diabetes
Pre-Clinical
Pre-Clinical
Feline Anemia
Pre-Clinical
Pre-Clinical
Chronic Pain
Pre-Clinical
Pre-Clinical
Atopic Dermatitis
Pre-Clinical
Pre-Clinical
Mitral Valve Disease
Optimization
Optimization
Canine Senescence
Optimization
Optimization
Osteoarthritis
Optimization
Optimization
Animal Health Oncology Pipeline
DISEASE & PRODUCT
RESEARCH
OPTIMIZATION
PRE-CLINICAL
PHASE I
PHASE II
PHASE III
MARKET LAUNCH
INVIVO-mAb Anti CTLA4
Phase III
Phase III
Melanoma
Phase III
Phase III
Sarcoma
Phase II
Phase II
Squamous Cell Carcinoma
Pre-Clinical
Pre-Clinical
Transitional Cell Carcinoma
Pre-Clinical
Pre-Clinical
IL-12
Phase III
Phase III
GM-CSF
Phase III
Phase III
INVIVO-mAb Anti PDL-1
Pre-Clinical
Pre-Clinical
INVIVO-mAb Bi-Specific
Research
Research
